BDBM508590 8-{2-[(2R)-4-(4-chloro-1,2,5- thiadiazol-3-yl)-2- methylpiperazin-1-yl]ethyl}- 2,2-difluoro[1,3]dioxolo[4,5- h][1,2,4]triazolo[1,5- c]quinazolin-5-amine::US11046714, Example 46

SMILES C[C@@H]1CN(CCN1CCc1nc2c3ccc4OC(F)(F)Oc4c3nc(N)n2n1)c1nsnc1Cl

InChI Key InChIKey=GRNGMGWDQXERDK-SECBINFHSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 508590   

TargetAdenosine receptor A2a(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM508590(8-{2-[(2R)-4-(4-chloro-1,2,5- thiadiazol-3-yl)-2- ...)
Affinity DataKi:  1.80nMAssay Description:The following table shows representative data for the compounds of the Examples as A2a receptor antagonists as determined by a competition binding as...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent